Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jafar Akbari, Majid Saeedi, Fatemeh Ahmadi, Seyyed Mohammad Hassan Hashemi, Amirhossein Babaei, Sadra Yaddollahi, Seyyed Sohrab Rostamkalaei, Kofi Asare-Addo & Ali Nokhodchi. (2022) Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration. Pharmaceutical Development and Technology 27:5, pages 525-544.
Read now
Read now
Raman Rohilla, Tarun Garg, Amit K. Goyal & Goutam Rath. (2016) Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Delivery 23:5, pages 1645-1661.
Read now
Read now
Bharti Gaba, Mohammad Fazil, Asgar Ali, Sanjula Baboota, Jasjeet K. Sahni & Javed Ali. (2015) Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Delivery 22:6, pages 691-700.
Read now
Read now
Articles from other publishers (32)
Samarjit Ghosh, Triveni Tiwari, Upendra Nagaich & Neha Jain. (2023) A Detailed Insight into Nanostructured Lipid Carriers: A Versatile Drug
Delivery System. Recent Patents on Nanotechnology 17:4, pages 284-306.
Crossref
Crossref
Jisan Ahamed, B.H. Jaswanth Gowda, Waleed H. Almalki, Neelima Gupta, Amirhossein Sahebkar & Prashant Kesharwani. (2023) Recent advances in nanoparticle-based approaches for the treatment of brain tumors: Opportunities and challenges. European Polymer Journal 193, pages 112111.
Crossref
Crossref
Jivesh Garg, Khushboo Pathania, Sangeeta Pilkhwal Sah & Sandip V. Pawar. (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
De-feng Li, Mei-feng Yang, Hao-ming Xu, Min-zheng Zhu, Yuan Zhang, Cheng-mei Tian, Yu-qiang Nie, Jian-yao Wang, Yu-jie Liang, Jun Yao & Li-sheng Wang. (2022) Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. Journal of Materials Chemistry B 10:31, pages 5853-5872.
Crossref
Crossref
Mohammed Elmowafy & Mohammad M. Al-Sanea. (2021) Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharmaceutical Journal 29:9, pages 999-1012.
Crossref
Crossref
Mohamed Sharaf, Muhammad Arif, Sohaib Khan, Mohnad Abdalla, Samah Shabana, Zhe Chi & Chenguang Liu. (2021) Co-delivery of hesperidin and clarithromycin in a nanostructured lipid carrier for the eradication of Helicobacter pylori in vitro. Bioorganic Chemistry 112, pages 104896.
Crossref
Crossref
Anan Yaghmur & Huiling Mu. (2021) Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharmaceutica Sinica B 11:4, pages 871-885.
Crossref
Crossref
Bavani Subramaniam, Zahid H. Siddik & Noor Hasima Nagoor. (2020) Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. Journal of Nanoparticle Research 22:6.
Crossref
Crossref
Kuldeep Rajpoot. (2020) Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications. Current Cancer Drug Targets 20:4, pages 271-287.
Crossref
Crossref
Priya Shrivastava, Sonal Vyas, Rajeev Sharma, Nishi Mody, Laxmikant Gautam, Anamika Jain, Nikhar Vishwakarma & Suresh P. Vyas. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery
473
498
.
Vedanti R. Salvi & Pravin Pawar. (2019) Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology 51, pages 255-267.
Crossref
Crossref
Anna Czajkowska-Kośnik, Marta Szekalska & Katarzyna Winnicka. (2019) Nanostructured lipid carriers: A potential use for skin drug delivery systems. Pharmacological Reports 71:1, pages 156-166.
Crossref
Crossref
Sarwar Beg, Hani Choudhry, Mazin A Zamzami, Khalid S Alharbi, Mahfoozur Rahman & Bhupinder Singh. (2018) Nanocolloidal lipidic carriers of olmesartan medoxomil surface-tailored with Concavalin-A for lectin receptor targeting. Nanomedicine 13:24, pages 3107-3128.
Crossref
Crossref
Catarina Leal Seabra, Cláudia Nunes, Manuela Brás, Maria Gomez-Lazaro, Celso A. Reis, Inês C. Gonçalves, Salette Reis & M. Cristina L. Martins. (2018) Lipid nanoparticles to counteract gastric infection without affecting gut microbiota. European Journal of Pharmaceutics and Biopharmaceutics 127, pages 378-386.
Crossref
Crossref
Neha Shrestha, Oriane Bouttefeux, Kevin Vanvarenberg, Patrik Lundquist, Juan Cunarro, Sulay Tovar, Georgiy Khodus, Ellen Andersson, Åsa V. Keita, Carlos Gonzalez Dieguez, Per Artursson, Véronique Préat & Ana Beloqui. (2018)
The stimulation of GLP-1 secretion and delivery of GLP-1 agonists
via
nanostructured lipid carriers
. Nanoscale 10:2, pages 603-613.
Crossref
Crossref
Rajan Jog & Diane J. Burgess. 2018. Fundamentals of Nanoparticles. Fundamentals of Nanoparticles
279
342
.
Ana Beloqui, Ana del Pozo-Rodríguez, Arantxazu Isla, Alicia Rodríguez-Gascón & María Ángeles Solinís. (2017) Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs. Journal of Drug Delivery Science and Technology 42, pages 144-154.
Crossref
Crossref
Narendar Dudhipala & Kishan Veerabrahma. (2017) Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability. Therapeutic Delivery 8:2, pages 79-88.
Crossref
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de VoordeAlejandro Sosnik. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production
579
602
.
Ana Beloqui, Mireille Alhouayek, Dario Carradori, Kevin Vanvarenberg, Giulio G. Muccioli, Patrice D. Cani & Véronique Préat. (2016) A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells. Molecular Pharmaceutics 13:12, pages 4222-4230.
Crossref
Crossref
Simeng Mu, Mo Li, Mengran Guo, Wenqian Yang, Yongjun Wang, Jingru Li, Qiang Fu & Zhonggui He. (2016) Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers. Colloids and Surfaces B: Biointerfaces 147, pages 73-80.
Crossref
Crossref
Neelam Poonia, Rajeev Kharb, Viney Lather & Deepti Pandita. (2016) Nanostructured lipid carriers: versatile oral delivery vehicle. Future Science OA 2:3, pages FSO135.
Crossref
Crossref
Yongtai Zhang, Zhe Li, Kai Zhang, Gang Yang, Zhi Wang, Jihui Zhao, Rongfeng Hu & Nianping Feng. (2016) Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans -ferulic acid ascompared with conventional solid lipid nanoparticles. International Journal of Pharmaceutics 511:1, pages 57-64.
Crossref
Crossref
Ana Beloqui, Patrick B. Memvanga, Régis Coco, Sonia Reimondez-Troitiño, Mireille Alhouayek, Giulio G. Muccioli, María José Alonso, Noemi Csaba, María de la Fuente & Véronique Préat. (2016) A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Colloids and Surfaces B: Biointerfaces 143, pages 327-335.
Crossref
Crossref
Kun Wan, Lili Sun, Xueyuan Hu, Zijun Yan, Yonghong Zhang, Xue Zhang & Jingqing Zhang. (2016) Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin. International Journal of Pharmaceutics 504:1-2, pages 80-88.
Crossref
Crossref
Ana Beloqui, María Ángeles Solinís, Alicia Rodríguez-Gascón, António J. Almeida & Véronique Préat. (2016) Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: Nanotechnology, Biology and Medicine 12:1, pages 143-161.
Crossref
Crossref
Susan Hua, Ellen Marks, Jennifer J. Schneider & Simon Keely. (2015) Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue. Nanomedicine: Nanotechnology, Biology and Medicine 11:5, pages 1117-1132.
Crossref
Crossref
Shilpa Chaudhary, Tarun Garg, R.S.R. Murthy, Goutam Rath & Amit K. Goyal. (2015) Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway. International Journal of Pharmaceutics 485:1-2, pages 108-121.
Crossref
Crossref
Ying Liu, Lan Wang, Yiqing Zhao, Man He, Xin Zhang, Mengmeng Niu & Nianping Feng. (2014) Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. International Journal of Pharmaceutics 476:1-2, pages 169-177.
Crossref
Crossref
Tengfei Weng, Jianping Qi, Yi Lu, Kai Wang, Zhiqiang Tian, Kaili Hu, Zongning Yin & Wei Wu. (2014) The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations. Journal of Nanobiotechnology 12:1.
Crossref
Crossref
Ana Beloqui, María Ángeles Solinís, Anne des Rieux, Véronique Préat & Alicia Rodríguez-Gascón. (2014) Dextran–protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs. International Journal of Pharmaceutics 468:1-2, pages 105-111.
Crossref
Crossref
Josune Torrecilla, Alicia Rodríguez-Gascón, María Ángeles Solinís & Ana del Pozo-Rodríguez. (2014) Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives. BioMed Research International 2014, pages 1-17.
Crossref
Crossref